BioEclipse Therapeutics, Inc.

CIK: 1780708DEIncorporated: 2006-05-26

Current Offering

$10,001
Target Amount
$1,069,998
Maximum Amount
2022-03-01
Deadline

Security Details

Type: Common Stock
Price per share: $2.55
Shares offered: 3,922+

Offering Costs

Cash commission: 5%
Up to 4.9% of amount raised for a successful offering and a listing fee of up to $5,000
Equity compensation: 0%
None.

Financial Reports

Offering via NetCapital Funding Portal Inc.

Offering History

As of 2022-01-19
Raising $10,001 -$1,069,998 via 3,922+ shares of common Stock at $2.55 per share
Deadline: 2022-03-01
As of 2022-02-28
Raising $10,001 -$1,069,998 via 3,922+ shares of common Stock at $2.55 per share
Deadline: 2022-04-01
As of 2022-04-01
Raising $10,001 -$1,069,998 via 3,922+ shares of common Stock at $2.55 per share
Deadline: 2022-04-19
Filing date2022-01-19
Current employees5
Act received most recent fiscal year$0.00
Act received prior fiscal year$0.00
Cash equi most recent fiscal year$2,331,499
Cash equi prior fiscal year$5,394,836
Cost goods sold most recent fiscal year$0.00
Cost goods sold prior fiscal year$0.00
Long term debt most recent fiscal year$0.00
Long term debt prior fiscal year$0.00
Net income most recent fiscal year-$4,391,188.00
Net income prior fiscal year-$2,415,736.00
Revenue most recent fiscal year$0.00
Revenue prior fiscal year$0.00
Short term debt most recent fiscal year$75,862
Short term debt prior fiscal year$0.00
Tax paid most recent fiscal year$0.00
Tax paid prior fiscal year$0.00
Total asset most recent fiscal year$2,956,073
Total asset prior fiscal year$5,839,337

Company Information

Corporation
DE
2006-05-26

Latest Metrics

Employees5
Total Assets$2,956,073
Cash on Hand$2,331,499
Revenues$0.00
Net Income-$4,391,188.00

Crowdfunding Portals

This company is raising funds through this portal